Invention Grant
- Patent Title: Chemical compounds
- Patent Title (中): 化合物
-
Application No.: US13038245Application Date: 2011-03-01
-
Publication No.: US08436167B2Publication Date: 2013-05-07
- Inventor: Rebecca Jane Booth , Peter Anthony Cittern , Jeffrey Norman Crabb , John Horbury , David Wyn Calvert Jones
- Applicant: Rebecca Jane Booth , Peter Anthony Cittern , Jeffrey Norman Crabb , John Horbury , David Wyn Calvert Jones
- Applicant Address: GB London
- Assignee: AstraZeneca UK Limited
- Current Assignee: AstraZeneca UK Limited
- Current Assignee Address: GB London
- Agency: Morgan, Lewis & Bockius LLP
- Priority: GB03211237.3 20030910; GB0404859.1 20040304
- Main IPC: C07D239/36
- IPC: C07D239/36 ; C07D239/42
Abstract:
Two polymorphic forms of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt, processes for making them and their use as HMG Co-A reductase inhibitors are described.
Public/Granted literature
Information query
